NCT06056271 - Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation | Biotech Hunter

Enrollment

400

Participants

Timeline

Start Date

March 19, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Atrial Fibrillation

Interventions

DEVICE

AF Ablation

Percutaneous, catheter-based ablation of atrial fibrillation

Trial Locations (4)

RECRUITING

Northwell Health, New York

RECRUITING

Ohio State University, Columbus

RECRUITING

Endeavor Health, Evanston

RECRUITING

Kansas City Cardiac Arrhythmia Research LLC, Overland Park